Today: 28 June 2026
Browse Category

NASDAQ:NBIX 7 April 2026

Soleno Therapeutics Pulls Europe Drug Filing After $2.9 Billion Neurocrine Deal

Soleno Therapeutics Pulls Europe Drug Filing After $2.9 Billion Neurocrine Deal

Soleno Therapeutics withdrew its European filing for VIOKAT on Tuesday, halting a regulatory review that was expected to conclude in 2026. The move came one day after Neurocrine Biosciences agreed to acquire Soleno for $2.9 billion in cash, or $53 a share. Vykat XR, Soleno’s only marketed product, generated $190.4 million in 2025 U.S. sales. Neurocrine said it has no immediate plans for a European launch.
7 April 2026
···
Soleno Therapeutics Stock Jumps After Neurocrine’s $2.9 Billion Bet on Vykat XR

Soleno Therapeutics Stock Jumps After Neurocrine’s $2.9 Billion Bet on Vykat XR

Neurocrine Biosciences will acquire Soleno Therapeutics for $53 a share in cash, valuing Soleno at $2.9 billion. The deal gives Neurocrine Vykat XR, the only FDA-approved treatment for hyperphagia in Prader-Willi syndrome. Soleno shares last traded at $52.25. The transaction is expected to close within 90 days, pending regulatory and shareholder approval.
7 April 2026
···

Stock Market Today

  • Goldman Sachs Shares Pull Back 7% After 50% Annual Gain; Valuation Seen Slightly Overvalued
    June 28, 2026, 4:22 AM EDT. Goldman Sachs (GS) shares closed at $1,019.61 on June 28, down 7% over the past week but up 50.6% over the last year. Despite a strong three-year gain of 239.1%, the stock showed a recent pullback. Valuation analysis using an Excess Returns model indicates the stock is about 10.4% overvalued, with an intrinsic value estimated at $923.45 versus the current price. Investors are advised to carefully consider Price-to-Earnings (P/E) ratios and valuation models amid robust long-term gains and evolving market conditions before making new investment decisions.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 28.06.2026

28 June 2026
LIVEMarkets rolling coverageStarted: June 28, 2026, 4:00 AM EDTUpdated: June 28, 2026, 4:28 AM EDT Goldman Sachs Shares Pull Back 7% After 50% Annual Gain; Valuation Seen Slightly Overvalued June 28, 2026, 4:22 AM EDT. Goldman Sachs (GS) shares closed at $1,019.61 on June 28, down 7% over the past week but up 50.6% over the last year. Despite a strong three-year gain of 239.1%, the stock showed a recent pullback. Valuation analysis using an Excess Returns model indicates the stock is about 10.4% overvalued, with an intrinsic value estimated at $923.45 versus the current price. Investors are advised to
Go toTop